Clinical Trial Update: A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial of NOX66 with external beam radiotherapy in metastatic castration-resistant prostate cancer and other solid tumors was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Solid Tumors

Drugs mentioned

• NOX66

Snippet

Sponsor: Noxopharm Limited | Conditions: Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-18